Systemic Vasculitis: Clinical Trials

4 trials for Systemic Vasculitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Systemic Vasculitis: new trials by email Literature Review of Systemic Vasculitis trials Research Report on Systemic Vasculitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease
13-valent pneumococcal conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine - Rheumatoid Arthritis, Systemic Lupus
Phase 4CompletedRegion Skane3002016-06-142023-03-29
A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
Methylprednisolone, Prednisone, Rituximab - Wegener's Granulomatosis or Microscopic Polyangiitis
Phase 4CompletedHoffmann-La Roche302015-07-062022-07-06
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
Glucocorticoids, Rituximab - Granulomatosis With Polyangiitis, Microscopic Polyangiitis
Phase 4CompletedMassachusetts General Hospital202014-06-012021-06-25
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
prednisone, methylprednisolone,cyclophosphamides, Cyclophosphamide, Azathioprine,prednisone,methylprednisolone, Mycophenolate mofetil,methotrexate - Vasculitis, Wegener's Granulomatosis
Phase 4CompletedAssistance Publique - Hôpitaux de Paris1082005-07-012011-09-12

Narrower conditions

Granulomatosis with Polyangiitis (3)  ·  Microscopic Polyangiitis (3)  ·  Arthritis, Rheumatoid (1)  ·  Churg-Strauss Syndrome (1)  ·  Pneumococcal Infections (1)  ·  Polyarteritis Nodosa (1)  ·  Sjogren's Syndrome (1)  ·  Spondylarthritis (1)  ·  Vasculitis (1)

Broader conditions

Autoimmune Diseases (4)  ·  Cardiovascular Diseases (4)  ·  Immune System Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Vascular Diseases (4)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Cerebral Small Vessel Diseases (3)  ·  Cerebrovascular Disorders (3)  ·  Lung Diseases (3)  ·  Lung Diseases, Interstitial (3)  ·  Nervous System Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Skin Diseases (3)

Interventions

Prednisone (3)  ·  Methylprednisolone (2)  ·  Rituximab (2)  ·  13-valent pneumococcal vaccine (1)  ·  23-valent pneumococcal capsular polysaccharide vaccine (1)  ·  Azathioprine (1)  ·  Cyclophosphamide (1)  ·  Glucocorticoids (1)  ·  Methotrexate (1)  ·  Mycophenolic Acid (1)  ·  Pneumococcal Vaccines (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Hoffmann-La Roche (1)  ·  Massachusetts General Hospital (1)  ·  Region Skane (1)

Countries

France (1)  ·  India (1)  ·  United States (1)

Top investigators

Jehns Martineus, MD (1)  ·  John H Stone, MD (1)

Results publications

PMID 25693055, PMID 32087733